Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CRP C-Reactive Protein (Human)

<strong>CRP C-Reactive Protein (Human)</strong> <strong>Catalog number:</strong> B2021219 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> PTX1, pentaxin, pentraxin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: a critical update. *Journal of Clinical Investigation*, 111(12), 1805-1812. 2. Kaptoge, S., et al. (2010). C-reactive protein, fibrinogen, and cardiovascular disease prediction. *New England Journal of Medicine*, 362(1), 1-10. 3. Ridker, P. M., et al. (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. *New England Journal of Medicine*, 342(12), 836-843. 4. Sproston, N. R., & Ashworth, J. J. (2018). Role of C-reactive protein at the site of inflammation and its potential as a therapeutic target. *Frontiers in Immunology*, 9, 1-10. 5. Danesh, J., et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. *New England Journal of Medicine*, 350(14), 1387-1397. 6. Libby, P., & Ridker, P. M. (2004). Inflammation and atherothrombosis: from basic research to clinical practice. *American Heart Journal*, 148(1), 1-8. 7. Hwang, S. J., et al. (2007). C-reactive protein and the risk of developing diabetes. *Diabetes Care*, 30(4), 1000-1005. 8. Kwan, T. W., et al. (2015). C-reactive protein and the risk of developing hypertension: a systematic review and meta-analysis. *Journal of Hypertension*, 33(4), 674-681. 9. Tzeng, J. I., et al. (2016). C-reactive protein and the risk of stroke: a meta-analysis. *Stroke*, 47(1), 1-7. 10. Wang, Y., et al. (2016). C-reactive protein and risk of cancer: a systematic review and meta-analysis. *Cancer Epidemiology, Biomarkers & Prevention*, 25(1), 1-10. <a href="CRP C-Reactive Protein">https://pubmed.ncbi.nlm.nih.gov/?term=CRP C-Reactive Protein</a> <br><strong>Products Related to CRP C-Reactive Protein (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2021219 (10 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD53 (161-2), CF740 conjugate, 0.1mg/mL
BNC740324-500 1x 500 µL

CD53 (161-2), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL
BNC881073-500 1x 500 µL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD104 (UM-A9), CF594 conjugate, 0.1mg/mL
BNC940449-100 1x 100 µL

CD104 (UM-A9), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD3e (RIV9), CF680R conjugate, 0.1mg/mL
BNC810322-100 1x 100 µL

CD3e (RIV9), CF680R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TNF alpha (J2D10), CF488A conjugate, 0.1mg/mL
BNC880994-100 1x 100 µL

TNF alpha (J2D10), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD43 (84-3C1), CF647 conjugate, 0.1mg/mL
BNC470342-100 1x 100 µL

CD43 (84-3C1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details